Search results
EXCLUSIVE: Woman, 64, diagnosed with cancer in knee after several doctors dismissed her first...
TODAY via Yahoo News· 1 day agoThis means treatment for sarcoma hasn’t advanced in the past 25 years. Treatment typically includes...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 11 hours agoIts pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street |...
The Motley Fool· 2 days agoSummit Therapeutics (SMMT -1.96%) is sizzling hot this year, with its shares skyrocketing around...
Dr. Roach: The cause behind a case of CMML seems to be unknown
St. Louis Post-Dispatch· 5 days agoDr. Roach: My husband recently passed away one week after his 80th birthday. According to his death certificate, he died of lung cancer (not a surprise) and chronic myelomonocytic leukemia ( ...
FDA Expands Pembrolizumab Approval for Endometrial Cancer
Medscape· 20 hours agoThe FDA expanded the approval of pembrolizumab based on improved PFS in patients with advanced or...
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe PD-1 inhibitor landscape is currently dominated by MSD’s Keytruda (pembrolizumab) and Bristol...
Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 6 days agoWe recently published a list entitled Billionaire Israel Englander’s Top 10 Stock Picks for 2024....